Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Gpatch2l | Rat | (-)-demecolcine | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Demecolcine results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | Gpatch2l | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Gpatch2l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36331819 | Gpatch2l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPATCH2L mRNA | CTD | PMID:22298810 | Gpatch2l | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36041667 | Gpatch2l | Rat | acrolein | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GPATCH2L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GPATCH2L mRNA | CTD | PMID:32699268 | Gpatch2l | Rat | aflatoxin B1 | increases methylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of GPATCH2L gene | CTD | PMID:27153756 | Gpatch2l | Rat | alpha-pinene | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GPATCH2L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GPATCH2L mRNA | CTD | PMID:32699268 | Gpatch2l | Rat | antirheumatic drug | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of GPATCH2L mRNA | CTD | PMID:24449571 | Gpatch2l | Rat | Benoxacor | increases expression | ISO | Gpatch2l (Mus musculus) | 6480464 | benoxacor results in increased expression of GPATCH2L mRNA | CTD | PMID:34850242 | Gpatch2l | Rat | benzo[a]pyrene | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GPATCH2L mRNA | CTD | PMID:20106945 and PMID:21632981 | Gpatch2l | Rat | benzo[a]pyrene | affects methylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GPATCH2L promoter | CTD | PMID:27901495 | Gpatch2l | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | Gpatch2l | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GPATCH2L mRNA | CTD | PMID:25181051 | Gpatch2l | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36041667 | Gpatch2l | Rat | bisphenol F | increases expression | ISO | Gpatch2l (Mus musculus) | 6480464 | bisphenol F results in increased expression of GPATCH2L mRNA | CTD | PMID:38685157 | Gpatch2l | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36041667 | Gpatch2l | Rat | bortezomib | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Bortezomib results in increased expression of GPATCH2L mRNA | CTD | PMID:20977926 | Gpatch2l | Rat | caffeine | affects phosphorylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of GPATCH2L protein | CTD | PMID:35688186 | Gpatch2l | Rat | clofibrate | increases expression | ISO | Gpatch2l (Mus musculus) | 6480464 | Clofibrate results in increased expression of GPATCH2L mRNA | CTD | PMID:23811191 | Gpatch2l | Rat | copper(II) sulfate | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of GPATCH2L mRNA | CTD | PMID:19549813 | Gpatch2l | Rat | coumestrol | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of GPATCH2L mRNA | CTD | PMID:19167446 | Gpatch2l | Rat | cyclosporin A | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GPATCH2L mRNA | CTD | PMID:25562108 | Gpatch2l | Rat | Dibutyl phosphate | affects expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of GPATCH2L mRNA | CTD | PMID:37042841 | Gpatch2l | Rat | dichloroacetic acid | increases expression | ISO | Gpatch2l (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of GPATCH2L mRNA | CTD | PMID:28962523 and PMID:34850242 | Gpatch2l | Rat | dorsomorphin | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH2L mRNA | CTD | PMID:27188386 | Gpatch2l | Rat | epoxiconazole | increases expression | ISO | Gpatch2l (Mus musculus) | 6480464 | epoxiconazole results in increased expression of GPATCH2L mRNA | CTD | PMID:35436446 | Gpatch2l | Rat | ethanol | affects splicing | ISO | Gpatch2l (Mus musculus) | 6480464 | Ethanol affects the splicing of GPATCH2L mRNA | CTD | PMID:30319688 | Gpatch2l | Rat | ethyl methanesulfonate | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | Gpatch2l | Rat | formaldehyde | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | Gpatch2l | Rat | FR900359 | increases phosphorylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of GPATCH2L protein | CTD | PMID:37730182 | Gpatch2l | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of GPATCH2L mRNA | CTD | PMID:33387578 | Gpatch2l | Rat | irinotecan | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Irinotecan analog results in decreased expression of GPATCH2L mRNA | CTD | PMID:18927307 | Gpatch2l | Rat | leflunomide | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | leflunomide results in increased expression of GPATCH2L mRNA | CTD | PMID:28988120 | Gpatch2l | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of GPATCH2L gene | CTD | PMID:35440735 | Gpatch2l | Rat | methyl methanesulfonate | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | Gpatch2l | Rat | methylmercury chloride | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of GPATCH2L mRNA | CTD | PMID:28001369 | Gpatch2l | Rat | methylmercury chloride | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of GPATCH2L mRNA | CTD | PMID:28001369 | Gpatch2l | Rat | nickel sulfate | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of GPATCH2L mRNA | CTD | PMID:16780908 | Gpatch2l | Rat | ozone | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GPATCH2L mRNA more ... | CTD | PMID:32699268 | Gpatch2l | Rat | ozone | multiple interactions | ISO | Gpatch2l (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GPATCH2L mRNA | CTD | PMID:34911549 | Gpatch2l | Rat | paracetamol | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GPATCH2L mRNA | CTD | PMID:21420995 | Gpatch2l | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GPATCH2L mRNA | CTD | PMID:33387578 | Gpatch2l | Rat | pentanal | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | pentanal results in decreased expression of GPATCH2L mRNA | CTD | PMID:26079696 | Gpatch2l | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Gpatch2l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36331819 | Gpatch2l | Rat | poly(I:C) | multiple interactions | EXP | | 6480464 | [Poly I-C co-treated with HU 211] results in decreased expression of GPATCH2L mRNA | CTD | PMID:26923065 | Gpatch2l | Rat | quercetin | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Quercetin results in increased expression of GPATCH2L mRNA | CTD | PMID:21632981 | Gpatch2l | Rat | SB 431542 | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH2L mRNA | CTD | PMID:27188386 | Gpatch2l | Rat | sodium arsenite | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GPATCH2L mRNA | CTD | PMID:38568856 | Gpatch2l | Rat | thiram | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Thiram results in increased expression of GPATCH2L mRNA | CTD | PMID:38568856 | Gpatch2l | Rat | trichostatin A | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GPATCH2L mRNA | CTD | PMID:26272509 | Gpatch2l | Rat | trichostatin A | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH2L mRNA | CTD | PMID:27188386 | Gpatch2l | Rat | triphenyl phosphate | affects expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of GPATCH2L mRNA | CTD | PMID:37042841 | Gpatch2l | Rat | urethane | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Urethane results in increased expression of GPATCH2L mRNA | CTD | PMID:28818685 | Gpatch2l | Rat | valproic acid | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GPATCH2L mRNA | CTD | PMID:23179753 | Gpatch2l | Rat | valproic acid | affects expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GPATCH2L mRNA | CTD | PMID:25979313 | Gpatch2l | Rat | vincristine | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Vincristine results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | |